BLB&B Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Buy |
|
|||||
|
2025
Q1 | $225K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $251K | Hold |
|
|||||
|
2024
Q2 | $236K | Hold |
|
|||||
|
2024
Q1 | $263K | Sell |
|
|||||
|
2023
Q4 | $236K | Sell |
|
|||||
|
2023
Q3 | $235K | Sell |
|
|||||
|
2023
Q2 | $238K | Sell |
|
|||||
|
2023
Q1 | $254K | Sell |
|
|||||
|
2022
Q4 | $575K | Buy |
|
|||||
|
2022
Q3 | $240K | Sell |
|
|||||
|
2022
Q2 | $456K | Sell |
|
|||||
|
2022
Q1 | $493K | Sell |
|
|||||
|
2021
Q4 | $543K | Sell |
|
|||||
|
2021
Q3 | $585K | Buy |
|
|||||
|
2021
Q2 | $553K | Sell |
|
|||||
|
2021
Q1 | $654K | Sell |
|
|||||
|
2020
Q4 | $1.11M | Sell |
|
|||||
|
2020
Q3 | $1.19M | Sell |
|
|||||
|
2020
Q2 | $1.4M | Sell |
|
|||||
|
2020
Q1 | $1.43M | Sell |
|
|||||
|
2019
Q4 | $1.79M | Sell |
|
|||||
|
2019
Q3 | $1.66M | Sell |
|
|||||
|
2019
Q2 | $1.6M | Sell |
|
|||||
|
2019
Q1 | $1.79M | Sell |
|
|||||
|
2018
Q4 | $1.82M | Sell |
|
|||||
|
2018
Q3 | $2.04M | Sell |
|
|||||
|
2018
Q2 | $2.12M | Sell |
|
|||||
|
2018
Q1 | $2.1M | Buy |
|
|||||
|
2017
Q4 | $1.9M | Sell |
|
|||||
|
2017
Q3 | $2.56M | Sell |
|
|||||
|
2017
Q2 | $3.11M | Buy |
|
|||||
|
2017
Q1 | $2.95M | Buy |
|
|||||
|
2016
Q4 | $2.51M | Buy |
|
|||||
|
2016
Q3 | $2.73M | Buy |
|
|||||
|
2016
Q2 | $2.67M | Buy |
|
|||||
|
2016
Q1 | $2.38M | Buy |
|
|||||
|
2015
Q4 | $2.25M | Buy |
|
|||||
|
2015
Q3 | $1.96M | Buy |
|
|||||
|
2015
Q2 | $2.07M | Buy |
|
|||||
|
2015
Q1 | $1.65M | Buy |
|
|||||
|
2014
Q4 | $822K | Buy |
|
|||||
|
2014
Q3 | $696K | Buy |
|
|||||
|
2014
Q2 | $808K | Buy |
|
|||||
|
2014
Q1 | $802K | Buy |
|
|||||
|
2013
Q4 | $796K | Sell |
|
|||||
|
2013
Q3 | $758K | Sell |
|
|||||
|
2013
Q2 | $758K | Buy |
|